BioCryst's total assets for Q2 2026 were $557.85M, an increase of 19.95% from the previous quarter. MX:BCRX total liabilities were $1.01B for the fiscal quarter, a -0.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.